Ioannis Vathiotis

7PUBLICATIONS
65CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)Innate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 11, 2025
Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC.

Pablo Llerena, Hani Samarah, Kathryn Nunes

|Jun 05, 2024
Spatially Informed Gene Signatures for Response to Immunotherapy in Melanoma.

Thazin N Aung, Jonathan Warrell, Sandra Martinez-Morilla

|Apr 14, 2023
Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma.

Niki Gavrielatou, Ioannis Vathiotis, Thazin Nwe Aung

|Mar 24, 2023
Quantitative, Spatially Defined Expression of Leukocyte-associated Immunoglobulin-like Receptor in Non-small Cell Lung Cancer.

Thazin N Aung, Niki Gavrielatou, Ioannis A Vathiotis

|Oct 23, 2021
Association of PD-1/PD-L1 Co-location with Immunotherapy Outcomes in Non-Small Cell Lung Cancer.

Niki Gavrielatou, Yuting Liu, Ioannis Vathiotis

|Sep 01, 2021
Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer.

Ioannis A Vathiotis, Myrto K Moutafi, Prajan Divakar

Pageof 2